AAIC 2020

27.07.2020 - 31.07.2020
VIRTUAL Conference


"Discover our innovative platforms and proven solutions for advanced healthcare"

Join us on our virtual booth!

Shimadzu is a leading driver in developing healthcare solutions with technology developments ranging from advanced imaging systems for use in medical diagnosis and treatment, engineering mass spectrometry-based solutions for exploring ways to discover disease biomarkers as well as building MS solutions for daily routine quantitation in biological fluids. Discover all our solutions at the virtual booth!


Oral presentation ON-DEMAND

Title: Performances of the plasma Aβ biomarker in longitudinal data 
Akinori Nakamura, National Center for Geriatrics and Gerontology, Japan

Tuesday, July 28, 2020: 12:00 AM - 11:59 PM (Q&A TIME 8:00 AM - 8:25 AM)
ON-DEMAND SESSIONS: Biomarkers (Non-Neuroimaging): Blood Based Biomarkers



Poster #47112

Developing Topic Posters: Biomarkers
Tuesday, July 28, 2020: 12:00 AM - 11:59 PM 
Title: MALDI-TOF IP-MS quantification of plasma amyloid peptides in Alzheimer’s disease  
Author: Sylvain Lehmann, CHU Montpellier, France


Poster #39194

Posters: Biomarkers
Tuesday, July 28, 2020: 12:00 AM - 11:59
Title: Identification of ADAMTS4 as an APP-cleaving enzyme at 669 site in APP669-711 production pathway  
Author: Taisuke Tomita, The University of Tokyo, Japan


Poster #45810

Posters: Biomarkers
Tuesday, July 28, 2020: 12:00 AM - 11:59
Title: Studies on the Pragmatic Performance and Validity of a Plasma Amyloid β Measurement System by Immunoprecipitation-Mass Spectrometry 
Author: Naoki Kaneko, Shimadzu Corporation, Japan


Poster # 45884

Posters: Clinical Manifestations/Biomarkers
Wednesday, July 29, 2020: 12:00 AM - 11:59 PM
Title: Plasma Aβ biomarker associated with cognitive decline in preclinical Alzheimer’s disease 
Author: Yen Ying Lim, The Florey Institute of Neuroscience and Mental Health, Australia


Other posters


Title: Immunoprecipitation-mass spectrometry (IP-MS) for plasma amyloid-β can be conducted with several kinds of monoclonal antibodies
Author: Ritsuko Yoda, Shimadzu Corporation, Japan
Posters: Biomarkers


Title: Analysis of the amyloid β-related peptides in mouse plasma and cell culture media
Author: Naoki Kaneko, Shimadzu Corporation, Japan
Posters: Biomarkers


Tiltle: Mass Spectrometric Quantification of Tau Protein Isoforms in Human Cerebrospinal Fluid
Author: Yusaku Hioki, Shimadzu Corporation, Japan
Posters: Biomarkers


Title: Immunoassay for Plasma APP669-711‚ One Component of the Amyloid β Biomarker
Author: Naoki Kaneko, Shimadzu Corporation, Japan
Posters: Biomarkers


Amyloid MS Service:

Shimadzu recently developed the Amyloid Mass Spectrometry (MS) Service — a new simple, low-cost blood test for early screening of amyloid-positive subjects. (RUO)


Product Lineup


An affordable, robust Linear MALDI-TOF mass spectrometry for all laboratories requiring routine manual or automated analysis of a wide variety of sample classes.
Used to detect presence and ratio of amyloid beta in blood samples after immunoprecipitation.



"Benchtop linear MALDI-TOF Mass Spectrometer" A high-performance benchtop linear MALDI-TOF Mass Spectrometer designed for routine MALDI-based workflows. Ideal to develop new tests and profiling solutions.
Sample throughput is increased using solid-state laser and traceability is insured by a unique patented barcode reader on the system.



The LCMS-8060NX is a triple quadrupole mass spectrometer with high-class sensitivity and detection speeds together with proven robustness.
A perfect tool for clinical research and quantitation of phosphor-TAU in biological fluids.



The quadrupole time-of-flight (Q-TOF) LCMS-9030 system is a research grade mass spectrometer designed to deliver high-resolution, accurate-mass detection with incredibly fast data acquisition rates, allowing scientists to identify and quantify more compounds with greater confidence.


LABNIRS & LIGHTNIRS - Toward Next-Generation Optical Brain-Function Imaging

Just how the human brain functions remain one of the greatest unsolved puzzles. To solve this mystery, brain-function imaging for visualization of brain functions has developed rapidly in recent years. In particular, in vivo optical imaging by functional near-infrared spectroscopy (fNIRS) has attracted attention as a technique that supports next-generation brain science.
Utilizing its leading-edge science and technology, Shimadzu has developed the LABNIRS/LIGHTNIRS, thereby contributing to the still growing field of brain science



Top of This Page